Baker Brothers Advisors - REPROS THERAPEUTICS INC ownership

REPROS THERAPEUTICS INC's ticker is RPRX and the CUSIP is 76028H209. A total of 74 filers reported holding REPROS THERAPEUTICS INC in Q1 2015. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of REPROS THERAPEUTICS INC
ValueSharesWeighting
Q3 2015$14,533,000
+3.9%
1,955,9440.0%0.13%
+8.9%
Q2 2015$13,985,000
-18.6%
1,955,944
-2.2%
0.12%
-14.0%
Q1 2015$17,180,000
-13.8%
2,000,0000.0%0.14%
-29.9%
Q4 2014$19,940,000
-27.5%
2,000,000
-28.0%
0.20%
-41.0%
Q3 2014$27,509,000
-42.8%
2,778,6540.0%0.35%
-41.3%
Q2 2014$48,071,000
-2.5%
2,778,6540.0%0.59%
-6.1%
Q1 2014$49,293,000
-3.1%
2,778,6540.0%0.63%
-12.6%
Q4 2013$50,849,000
-31.7%
2,778,6540.0%0.72%
-32.2%
Q3 2013$74,468,000
+45.3%
2,778,6540.0%1.06%
+4.3%
Q2 2013$51,266,0002,778,6541.01%
Other shareholders
REPROS THERAPEUTICS INC shareholders Q1 2015
NameSharesValueWeighting ↓
SPHERA FUNDS MANAGEMENT LTD. 978,800$1,292,0000.33%
Allegis Investment Advisors, LLC 344,487$455,0000.14%
GENERAL AMERICAN INVESTORS CO INC 589,768$778,0000.08%
Acrospire Investment Management LLC 23,177$31,0000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 268,130$354,0000.01%
Alambic Investment Management, L.P. 16,091$21,0000.00%
OXFORD ASSET MANAGEMENT LLP 51,359$68,0000.00%
Renaissance Technologies 716,413$946,0000.00%
BENJAMIN F. EDWARDS & COMPANY, INC. 2,700$4,0000.00%
Virtu KCG Holdings LLC 45,144$60,0000.00%
View complete list of REPROS THERAPEUTICS INC shareholders